Clinical trials
Phase 2 Antiphospholipid Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2016 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 5 |
| Terminated | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hospital for Special Surgery, New York | 2 |
| Institute of Hematology & Blood Diseases Hospital, China | 2 |
| Ruijin Hospital | 2 |
| Cairo University | 1 |
| Hoffmann-La Roche | 1 |
| Johns Hopkins University | 1 |
| National and Kapodistrian University of Athens | 1 |
| Peking Union Medical College Hospital | 1 |
| Peking University People's Hospital | 1 |
| University College, London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Antiphospholipid Syndrome | 14 |
| Lupus Erythematosus, Systemic | 2 |
| Thrombocytopenia | 2 |
| Abortion, Habitual | 1 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 |
| Behcet Syndrome | 1 |
| Brain Ischemia | 1 |
| Immunoglobulin G4-Related Disease | 1 |
| Ischemic Stroke | 1 |
| Kidney Failure, Chronic | 1 |
Trials
Showing 51 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.